Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 5/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2122053 | 0.90 | ALDH1A1 (0.45) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL28439906 | 0.84 | — | — | |
| SCHEMBL1017559 | 0.81 | — | — | |
| SCHEMBL1240083 | 0.81 | TSHR (0.46) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL18196043 | 0.80 | ALDH1A1 (0.58) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL52388 | 0.79 | — | — | |
| SCHEMBL31576596 | 0.79 | — | — | |
| SCHEMBL19644551 | 0.79 | TSHR (0.50) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL19644556 | 0.79 | TSHR (0.50) | TSHRALDH1A1ABCC4MAPTTRPA1 | |
| SCHEMBL1016057 | 0.79 | TSHR (0.50) | TSHRALDH1A1ABCC4MAPTTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12053003-B2 | Animal feed supplement | MOTTRAL SA (CH) | 2024-08-06 | — | — | US | claimed |
| US-20220256890-A1 | ANIMAL FEED SUPPLEMENT AND ANIMAL FEED COMPOSITION | Mootral Innovations Limited (GB) | 2022-08-18 | — | — | US | claimed |
| EP-3996521-A1 | ANIMAL FEED SUPPLEMENT AND ANIMAL FEED COMPOSITION | Mootral Innovations Limited (GB) | 2022-05-18 | — | — | EP | claimed |
| WO-2021005202-A1 | ANIMAL FEED SUPPLEMENT AND ANIMAL FEED COMPOSITION | MOOTRAL SA (CH) | 2021-01-14 | — | — | WO | claimed |
| CN-111876748-A | Metal sulfide thin film based on organic sulfur precursor and preparation method thereof | 北京大学深圳研究生院 | 2020-11-03 | — | — | CN | claimed |
| US-20200170281-A1 | ANIMAL FEED SUPPLEMENT | MOOTRAL SA (CH) | 2020-06-04 | — | — | US | claimed |
| US-20200138056-A1 | ANIMAL FEED SUPPLEMENT | MOTTRAL SA (CH) | 2020-05-07 | — | — | US | claimed |
| EP-3629756-A1 | ANIMAL FEED SUPPLEMENT | Mootral SA (CH) | 2020-04-08 | — | — | EP | claimed |
| EP-3629757-A1 | ANIMAL FEED SUPPLEMENT | Mootral SA (CH) | 2020-04-08 | — | — | EP | claimed |
| CN-110944517-A | Animal feed supplement | 莫特迩公司 | 2020-03-31 | — | — | CN | claimed |
| WO-2018220338-A1 | ANIMAL FEED SUPPLEMENT | MOOTRAL SA (CH) | 2018-12-06 | — | — | WO | claimed |
| WO-2018220340-A1 | ANIMAL FEED SUPPLEMENT | MOOTRAL SA (CH) | 2018-12-06 | — | — | WO | claimed |
| US-20250235148-A1 | IBS RELATED TESTING AND TREATMENT | IBS-80, LLC | 2025-07-24 | — | — | US | disclosed |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | ARKEA BIO CORP (US) | 2025-07-10 | — | — | US | disclosed |
| US-20250186566-A1 | CELL-BASED VACCINES | ARKEA BIO CORP (US) | 2025-06-12 | — | — | US | disclosed |
| US-12053003-B2 | Animal feed supplement | MOTTRAL SA (CH) | 2024-08-06 | — | — | US | disclosed |
| CN-1171901-A | Horseradish-taste preparation and food having horseradish taste | HOUSE FOODS CORP (JP) | 1998-02-04 | — | — | CN | disclosed |
| WO-1997039355-A1 | PHARMACEUTICAL GRADE BOTANICAL DRUGS | PHARMAPRINT, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| US-5453420-A | Ethanol extract of garlic | SAKAI ISAO (JP) | 1995-09-26 | — | — | US | disclosed |
| EP-0347864-A2 | Anti-atherogenic agents | Strydom, Andries Johannes Cornelus (ZA) | 1989-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186566-A1 | CELL-BASED VACCINES | HAGH, HSD17B10, FH | TSHR 4160/4885ALDH1A1 1304/4885ABCC4 2896/4885 |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | MCRS1, VIP, HM13 | TSHR 3446/4885ALDH1A1 4837/4885ABCC4 3895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.